GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » KAINOS Laboratories Inc (TSE:4556) » Definitions » Total Equity

KAINOS Laboratories (TSE:4556) Total Equity : 円6,466 Mil (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is KAINOS Laboratories Total Equity?

KAINOS Laboratories's total equity for the quarter that ended in Sep. 2024 was 円6,466 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

KAINOS Laboratories Total Equity Historical Data

The historical data trend for KAINOS Laboratories's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KAINOS Laboratories Total Equity Chart

KAINOS Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,381.47 4,659.51 5,200.13 5,669.84 6,266.29

KAINOS Laboratories Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,715.60 5,955.32 6,182.78 6,266.29 6,465.66

KAINOS Laboratories Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

KAINOS Laboratories's Total Equity for the fiscal year that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=8590.984-2324.699
=6,266

KAINOS Laboratories's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=8440.341-1974.681
=6,466

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KAINOS Laboratories Total Equity Related Terms

Thank you for viewing the detailed overview of KAINOS Laboratories's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

KAINOS Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » KAINOS Laboratories Inc (TSE:4556) » Definitions » Total Equity
Comparable Companies
TSE:9340 TSE:7980 TSE:7782 TSE:3446 TSE:3604 TSE:7813 TSE:7702 TSE:7775 TSE:7743 TSE:3154 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
38-18, Hongo 2-chome, Bunkyo-ku, Tokyo, JPN
Website
http://www.kainos.co.jp
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.

KAINOS Laboratories Headlines

No Headlines